Biovica International AB (OSTO:BIOVIC B) Dividends per Share : kr0.00 (TTM As of Jul. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Dividends per Share?

Biovica International AB's dividends per share for the three months ended in Jul. 2024 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jul. 2024 was kr0.00. Its Dividend Payout Ratio for the three months ended in Jul. 2024 was 0.00. As of today, Biovica International AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Biovica International AB Dividends per Share Historical Data

The historical data trend for Biovica International AB's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Dividends per Share Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Dividends per Share

Get a 7-Day Free Trial

Biovica International AB Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biovica International AB's Dividends per Share

For the Biotechnology subindustry, Biovica International AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovica International AB's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Dividend Yield % falls into.

Biovica International AB Dividends per Share Calculation

Dividends paid to per common share.

Biovica International AB (OSTO:BIOVIC B) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Biovica International AB's Dividend Payout Ratio for the quarter that ended in Jul. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jul. 2024 )	/	EPS without NRI (Q: Jul. 2024 )
	=	0	/	-0.27
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Biovica International AB Dividends per Share Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines